does glp 1 cause breast cancer Glucagon-like peptide-1 medicines and cancer

For years, researchers have known that obesity is associated with an increased risk of developing and dying from several cancers, including breast cancer. At ASCO 2026, new studies examining GLP-1 receptor agonists

24.66

★★★★☆4.8 (126)

GLP-1 Medications for Weight Loss in Breast Cancer Patients

26.83

★★★★★4.9 (98)

GLP-1 users were about half as likely to progress to stage IV in 4 of 7 cancers (new ASCO data). The signal is real, but it isn't a reason to start one. :

24.89

★★★★★5.0 (157)

Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway

26.52

★★★★★4.7 (84)

GLP-1 drugs linked to major slowdown in cancer spread, new study finds

25.94

★★★★★4.9 (203)

There's a surprising new benefit from taking GLP-1 weight loss drugs—using the medication is associated with lower breast cancer incidents, according to a published study. Latest Medical Watch Daily Digest: ( https://wgntv.com/news/medical-watch/glp-1

24.94

★★★★★5.0 (176)

Glucagon-like peptide-1 medicines and cancer

20.08

★★★★★4.8 (132)